Local healthcare marketplace attracts investment from Japanese pharma titan

  • 📰 htxtafrica
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

Singapore News News

Singapore Singapore Latest News,Singapore Singapore Headlines

RecoMed attracts investment from Japanese pharmaceutical giant Eisai in the platform's biggest funding round to date.

While the value of the investment is unknown at this stage, RecoMed says this latest funding round was its biggest yet.On the back of a 150 percent increase in revenue, local digital healthcare marketplace, RecoMed has announced a sizable investment from

“The investment will be used to enhance our technology, drive awareness of the platform and build a more robust digital healthcare journey for patients. We are deeply committed to improving the patient treatment journey and overall outcomes across a range of diseases and, with our initial focus on breast cancer, we are firmly on the road to achieving this goal.”

“We engaged with RecoMed as they align with our goal to use digital platforms and technologies in order to streamline the entire patient journey, thus ultimately alleviating people’s anxiety over health and reducing health disparities,” says Shin Ujiie, Vice President of Corporate Strategy at Eisai.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 42. in SG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Singapore Singapore Latest News, Singapore Singapore Headlines